ASTH
Astrana Health·NASDAQ
--
--(--)
--
--(--)
5.00 / 10
Netural
Money flow analysis registers 7.74/10, showing robust fund flow characteristics. Positive momentum in overall, block, Small, Medium, and Extra-large is countered by negative tendencies in Large, suggesting positive flow conditions. Research analyst consensus shows predominantly positive analyst sentiment, demonstrating moderate confidence. Current ratings: Strong Buy(66.7%), Neutral(33.3%) across 3 coverage providers, supported by 2.25 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-24
InstitutionBarclays
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for ASTH?
- ASTH holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.00/10 (Netural).
